TrialBritish journal of cancer2024

NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.

Michael Cecchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.